. Author manuscript; available in PMC: 2015 Feb 1.

Published in final edited form as: Neuropharmacology. 2013 Oct 10;0:10.1016/j.neuropharm.2013.09.026. doi: 10.1016/j.neuropharm.2013.09.026

Table 5.

Social interaction data after D1 antagonist infusion in females.

anatomical hits		cage area time (s)		corners time (s)		open field		interaction ratio
anatomical hits		empty cage	novel mouse	empty cage	novel mouse	center time (s)	distance (m)	cage area	corners

control	aCSF (n=16)	91.27 ± 6.65	91.97 ± 10.62	7.22 ± 1.92	16.11 ± 9.31	31.58 ± 4.03	22.48 ± 3.50	95.62 ± 10.22	206.26 ± 52.79
control	2.5μg (n=9)	81.80 ± 16.20	88.74 ± 16.27	9.69 ± 3.55	6.57 ± 2.36	30.19 ± 6.90	15.92 ± 2.24	113.09 ± 26.19	258.52 ± 121.06
stress	aCSF (n=19)	103.17 ± 7.60	77.40 ± 10.17	5.36 ± 1.33	17.98 ± 5.92	32.12 ± 2.88	22.53 ± 2.26	76.22 ± 10.51	451.18 ± 111.12
stress	2.5μg (n=10)	79.64 ± 15.99	93.24 ± 18.37	7.00 ± 16.60	20.08 ± 17.78	28.65 ± 5.59	15.22 ± 3.53^*	135.18 ± 19.92^**	108.67 ± 30.39^**
anatomical misses
control	aCSF (n=3)	136.10 ± 4.39	143.83 ± 8.44	1.77 ± 1.52	0.2 ± 0.06	23.1 ± 1.43	18.39 ± 3.73	105.80 ± 6.06	92.36 ± 57.80
control	2.5μg (n=4)	88.18 ± 28.58	89.88 ± 20.00	1.73 ± 0.92	7.5 ± 5.71	14.18 ± 4.92	20.17 ± 3.63	183.02 ± 102.65	245.37 ± 245.37
stress	aCSF (n=3)	112.25 ± 28.99	117.48 ± 16.60	7.88 ± 3.76	13.25 ± 13.25	18.43 ± 3.34	18.11 ± 5.07	90.40 ± 14.67	58.33 ± 44.49
stress	2.5μg (n=7)	75.24 ± 14.10	73.13 ± 30.44	8.77 ± 4.86	27.8 ± 6.68	27.64 ± 6.68	20.43 ± 4.3	95.73 ± 29.29	186.33 ± 76.81

p<0.05 vs aCSF.

^**

p < 0.01 vs aCSF